Claudia Torres-Calzada

Dr. Claudia Torres-Calzada


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2024 in Metabolites
Verified
Journal Article
Open access
PDF file
YLYamile Lopez
Yamile Lopez
VLVictoria Lima-Rogel
Victoria Lima-Rogel
RMRupasri Mandal
Rupasri Mandal
JZJiamin Zheng
Jiamin Zheng
LZLun Zhang
Lun Zhang
David Scott WishartDavid Scott Wishart
David Scott Wishart
Maternal pathological conditions such as infections and chronic diseases, along with unexpected events during labor, can lead to life-threatening perinatal outcomes. These outcomes can have irreversible consequences throughout an individual’s entire life. Urinary metabolomics can provide valuable insights into early physiological adaptations in healthy newborns, as well as metabolic disturbances in premature infants or infants with birth complications. In the present study, we measured 180 metabolites and metabolite ratios in the urine of 13 healthy (hospital-discharged) and 38 critically ill newborns (admitted to the neonatal intensive care unit (NICU)). We used an in-house-developed targeted tandem mass spectrometry (MS/MS)-based metabolomic assay (TMIC Mega) combining liquid chromatography (LC-MS/MS) and flow injection analysis (FIA-MS/MS) to quantitatively analyze up to 26 classes of compounds. Average urinary concentrations (and ranges) for 167 different metabolites from 38 critically ill NICU newborns during their first 24 h of life were determined. Similar sets of urinary values were determined for the 13 healthy newborns. These reference data have been uploaded to the Human Metabolome Database. Urinary concentrations and ranges of 37 metabolites are reported for the first time for newborns. Significant differences were found in the urinary levels of 44 metabolites between healthy newborns and those admitted at the NICU. Metabolites such as acylcarnitines, amino acids and derivatives, biogenic amines, sugars, and organic acids are dysregulated in newborns with bronchopulmonary dysplasia (BPD), asphyxia, or newborns exposed to SARS-CoV-2 during the intrauterine period. Urine can serve as a valuable source of information for understanding metabolic alterations associated with life-threatening perinatal outcomes.

Verified
Journal Article
Open access
PDF file
LZLun Zhang
Lun Zhang
JZJiamin Zheng
Jiamin Zheng
RBRashid Ahmed Bux
Rashid Ahmed Bux
JHJean-Francois Haince
Jean-Francois Haince
CTClaudia Torres-Calzada
Claudia Torres-Calzada
David Scott WishartDavid Scott Wishart
David Scott Wishart
Early detection of lung cancer significantly improves survival, yet current screening methods have limitations. This study aimed to identify a robust panel of plasma metabolites for early-stage non-small cell lung cancer (NSCLC) diagnosis using a large, clinically diverse patient cohort. A total of 680 archived plasma samples from biopsy-confirmed NSCLC patients and controls (including healthy individuals and patients with non-cancerous lung diseases) were analyzed using targeted, quantitative mass spectrometry-based metabolomics and used as the discovery cohort. An independent set of 216 plasma samples served as the validation cohort. Logistic regression (LR) models developed from the discovery set using ten metabolites achieved area under the receiver-operating characteristic curve (AUROC) values of 93.63%, 93.74%, and 93.91% for distinguishing all-stage, stage I–II, and stage I NSCLC patients from controls, respectively. Incorporating smoking history further improved model performance. The validation cohort confirmed the model’s robustness, demonstrating high sensitivity and specificity for early-stage detection. These results support the potential of metabolomic biomarkers as a minimally invasive, accurate tool for early NSCLC diagnosis. This approach may complement current screening methods, enabling earlier intervention and improved patient outcomes. Further studies are warranted to validate these findings in more diverse populations and real-world clinical settings.

2 September 2026 in Biosensors
Verified
Journal Article
Open access
PDF file
Prashanthi KovurPrashanthi Kovur
Prashanthi Kovur
SMScott Mackay
Scott Mackay
SBSong Tian Bai
Song Tian Bai
JCJames Daniel Joseph Cook
James Daniel Joseph Cook
CTClaudia Torres-Calzada
Claudia Torres-Calzada
David Scott WishartDavid Scott Wishart
David Scott Wishart
Early detection of colorectal cancer (CRC) is challenging in low-resource settings because access to colonoscopy and centralized laboratory testing is limited. Urine-based metabolite biomarkers offer a non-invasive alternative for CRC triage, but translating a laboratory assay into a point-of-care (PoC) system requires standardized fluid handling, operator-independent timing, field-compatible reagents, and quantitative calibration. Here, we present a low-cost, semi-automated PoC platform integrating a validated, sequential, three-metabolite CRC-biomarker assay with robotic fluid handling, a motorized chromatographic module, an optical reader, Bluetooth electronics, and tablet-guided control. The platform measures urinary diacetylspermine and hippuric acid, with creatinine serving as a normalization reference, and reports absolute quantitative concentrations. Automated dilution, tube positioning, timed incubation, controlled column elution, and software-guided transfer reduce operator-dependent variation. Using pooled urine samples spiked at clinically relevant concentrations, the creatinine assay showed a strong quadratic response (0–50 mM, R2 = 0.998), as did the diacetylspermine assay (0–4 μM, R2 = 0.979), while the hippuric acid assay showed a linear response of R2 = 0.989. The RGB sensor tracked the concentration-dependent trend observed with a laboratory microplate reader (R2 = 0.968–0.999). Reagents reformulated as lyophilized or pre-weighed, vacuum-sealed kits withstood accelerated heat and humidity (45 °C/70% RH) testing and international shipping to the pilot site very well. At approximately USD 490 for the complete instrument (including tablet) and roughly USD 7.65 in consumables per screening test, the platform offers a practical, quantitative, and portable route for decentralized CRC screening.

28 October 2026 in Engineering Proceedings
Verified
Conference Paper
Open access
PDF file
Prashanthi KovurPrashanthi Kovur
Prashanthi Kovur
SMScott Mackay
Scott Mackay
ANAmeen Naqvi
Ameen Naqvi
JCJames Daniel Joseph Cook
James Daniel Joseph Cook
CTClaudia Torres-Calzada
Claudia Torres-Calzada
David Scott WishartDavid Scott Wishart
David Scott Wishart
Early detection of sheep pregnancy and litter size (PLS) is crucial for the efficient management of the flock. However, standard ultrasonography for these purposes is not cost-effective for flock testing and requires trained and experienced operators. We have developed a simple handheld, real-time RGB color-sensor system that can measure six PLS candidate biomarkers, namely L-carnitine, glucose, lactate, creatinine, urea, and pyruvate using six in-house colorimetric assays, and a companion tablet application to report sheep PLS results. A benchtop microplate reader was used to obtain the measurements of the six assays using spiked, pooled sheep serum to produce a set of assay-specific weighted “color numbers” which were then used to calibrate the portable sensor system. To facilitate pregnancy testing in sheep during the coldest months of Canadian winter, we have also developed a custom-made temperature-controlled heating chamber so that the colorimetric assays can be incubated at approximately 21 °C. Here, we report on outdoor, on-device calibration of two chemically distinct assays spanning the concentration ranges represented in the panel. Creatinine, measured using the non-enzymatic alkaline 3,5-dinitrobenzoic acid reaction, increased monotonically over a concentration range of 0–200 µM (linear fit, R2 = 0.9469). Urea, measured using the enzyme-coupled Berthelot reaction, increased rapidly up to about 10 mM before saturating (quadratic fit, R2 = 0.9864). Both assays produced repeatable and concentration-dependent color change under the variable outdoor winter conditions experienced on-farm and therefore, hold great promise for the on-farm colorimetric measurement of metabolites of interest for pregnancy and litter size in sheep.